Global Sertraline Market, By Strength (20mg, 25mg, 50mg, 100mg), Drug Class (Antidepressant, Selective Serotonin Reuptake Inhibitor (SSRI)), Application (Obsessive-Compulsive Disorder, Panic Disorder, Depression, Premenstrual Anxiety Disorder, Others), Demographic (Adult, Pediatric, Geriatric), Dosage Form (Tablet, Solution, Capsule, Others), Route of Administration (Oral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Sertraline Market
Sertraline market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.90% in the above mentioned forecast period.
Sertraline is a form of antidepressant which is associated with the drug class known as selective serotonin reuptake inhibitor (SSRI). It functions by increasing the level of serotonergic activity in the brain. It is referred to a prescription drug which is available in various dosage forms including tablet, solution, and capsule. It is also available as generic drug. Zoloft is the brand name for this drug. This medication is helpful in the treatment of obsessive-compulsive disorder, panic disorder, depression, bulimia nervosa and premenstrual anxiety disorder, among others.
The rise in the prevalence of anxiety and obsessive-compulsive disorder across the world will act a major driver for the expansion of sertraline market. Furthermore, increasing geriatric population, rising healthcare expenditure and increase in the number of patients suffering from depression are the factors that will expand the sertraline market. Other factors including rise in the growing demand for antidepressants, changing lifestyle and rising awareness will positively impact the market growth rate. Another significant factor is the rise in technical innovations associated with treatment of psychiatric diseases along with sertraline such as repetitive Transcranial Magnetic Stimulation Therapy (rTMS), transcranial magnetic stimulation therapy (TMS), and others will cushion the market’s growth rate.
Moreover, the rise in the research and development activities, new product launches and strategic collaborations will provide beneficial opportunities for the sertraline market in the forecast period of 2021-2028.
However, high cost of the drug and side effects associated with sertraline such as loss of appetite, eye pain, diarrhea, loss of coordination, headache, nausea, dizziness, seizures and others. All these factors hamper the market growth. Lack of awareness will further challenge the sertraline market in the forecast period mentioned above.
This sertraline market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sertraline market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sertraline Market Scope and Market Size
The sertraline market is segmented on the basis of strength, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of strength, the sertraline market is segmented into 20mg, 25mg, 50mg, and 100mg
- On the basis of drug class, the sertraline market is segmented into antidepressant, selective serotonin reuptake inhibitor (SSRI).
- On the basis of application, the sertraline market is segmented into obsessive-compulsive disorder, panic disorder, depression, premenstrual anxiety disorder and others.
- On the basis of demographic, the sertraline market is segmented into adult, pediatric and geriatric.
- On the basis of dosage form, the sertraline market is segmented into tablet, solution, capsule, and others.
- On the basis of route of administration, the sertraline market is segmented into oral and others.
- On the basis of end-users, the sertraline market is segmented into clinic, hospital and others.
The sertraline market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Sertraline Market Country Level Analysis
The sertraline market is segmented on the basis of strength, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel.
The countries covered in the sertraline market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the sertraline market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Sertraline market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Sertraline Market Share Analysis
Sertraline market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sertraline market research.
Some of the major players operating in the sertraline market are Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Mylan N.V., Apotex Inc., Sun Pharmaceutical Industries Ltd., Lupin, Torrent Pharmaceuticals Ltd., Pfizer Inc., Novartis AG, Accord Healthcare, Cipla Inc., WOCKHARDT, Gerot Lannach, DAIICHI SANKYO COMPANY, LIMITED, Zhejiang Jingxin Pharmaceutical Co., Ltd., Oxford Pharma, Allergan, Unimarck Pharma India Limited, Mitsubishi Tanabe Pharma Corporation, Genericon Pharma GmbH, and ANGITA, among others.
SKU-